time for patience
All of our patience has been tested beyond reason, especially those of us that have been around for 4 + years.
I think that Pierre is actually starting to understand his shortcomings.... From what I hear, this recent board meeting was exceptional....unlike any before it. The talented new blood, Kym Anthony, Andrea Clark, Vincent Taillefer and others apparently made a great contribution and hit the real issues head on.
Given we are on the verge of the CE Mark and the HUGE product launch... AND we are taking positive corporate governance and planning steps, I think this is the time for patience. The stock price will take care of itself.
While I think that all the negativity on the board is completely justified, I really think we have put in the lows on the stock and we will move higher with good news and positive corporate developments.
I cant say definitively what the plan is from a Cash perspective, but I wouldnt be at all surprised if it is JV or Unit sale related...ie: non-dilutive...
As rough as this year has been, I do truly think I am seeing positive signs and that we are currently significantly undervalued.
Add to this the fact that the institutional liquidation seems to be over. Acuity has sold virtually ALL of their position as has MD Capital. The good news is Phillips, Hager and North... AND Mackenzie Financial have increased their positions substantially. Both of these firms are quite conservative and interactive long term players with solid hands....very positive.
We are technically oversold and have the ability to snap back meaningfully when sentiment changes (and it will)
What we need is good news on the endogenous test, the CE Mark and lots of worldwide public recognition of our truly revolutionary product.... Follow that up with LEAD orders from the British, French and German Blood agencies. Then all we need is one, two, three, five institutions in buying...with little stock for sale... and we can be back at two dollars or higher before you can say Bovine Spongiform Encepatholopy..... we'll see